PRESS DIGEST- Financial Times - April 9
U.S. proposes tariffs on $11 bln of EU products over Airbus subsidies https://on.ft.com/2KiBU3Q
Debenhams lenders reject Sports Direct rescue plan https://on.ft.com/2Kix4Ue
GSK two-drug/one-pill HIV treatment given FDA approval in U.S. https://on.ft.com/2Kn6323
Overview The U.S. is weighing tariffs on $11 billion in EU products, including civilian aircraft and agricultural products ranging from Roquefort cheese to olive oil, in response to the World Trade Organization's rulings that found that Brussels had provided illegal subsidies to Airbus.
Struggling department store Debenhams Plc looks likely to be placed into a pre-pack administration after its lenders rejected major shareholder Sports Direct International Plc's recapitalisation plan. GlaxoSmithKline Plc's two-drug treatment for HIV was approved by U.S. Food and Drug Administration on Monday, giving it a significant boost in its battle for market share with American biotech Gilead Sciences Inc. (Compiled by Bengaluru newsroom)
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Financial Times
- World Trade Organization
- Fish products
- Avon Products
- OPI Products
- Auto Lenders of
- Lenders mortgage insurance
- Mortgage Lenders of America-
- Olive oil
- Airbus A380
- Airbus Group
- Airbus Helicopters
- Sports Direct
- Brussels Airlines
- Brussels sprout
- Brussels Agglomeration
- The Newsroom
- Newsroom Suites
- CNN Newsroom
- Reuters
ALSO READ
USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant
Jubilant gets VAI classification from USFDA for Roorkee unit
Health News Roundup: FDA classifies recall of Boston Scientific device as 'most serious';
Former JetBlue CEO Hayes to lead Airbus in North America
Health News Roundup: FDA classifies recall of Boston Scientific device as 'most serious'; Vanda adopts 'poison pill' after rejecting Future Pak's offer and more